Research seeks way to block euphoria associated with cocaine use


Research underway at UNT Health Science Center could lead to a medication to treat cocaine addiction.

Cocaine is a highly addictive drug, and about 80 percent of cocaine abusers relapse six months after leaving a rehabilitation facility.  A medication that could block the effects of cocaine might be useful as part of a rehabilitation program.

Currently there are no drugs that are FDA approved for the treatment of cocaine dependence.

“A better understanding of how cocaine might change dopamine receptor signaling in the brain may lay the foundation for developing new medications,” said Robert Luedtke, PhD, Professor of Pharmacology & Neuroscience.

Cocaine increases the amount of the neurotransmitter dopamine, leading to an intense feeling of euphoria. Drug use is often followed by depression and a craving for more cocaine.  Cocaine also causes hallucinations, mood disturbances, increased blood pressure and a heightened risk of heart attack and stroke.

Dr. Luedtke’s research focuses on the role of the dopamine D3 receptor in cocaine addiction.  If the D3 receptor is blocked, the cocaine abuser may no longer experience the euphoria he or she associates with cocaine, and it may diminish their motivation to seek the drug.  A drug that helps a cocaine abuser to avoid relapse could be an important part of a multi-pronged therapeutic approach, which would include both behavioral modification and pharmacological treatment.

“It is not likely that any medication alone is going to enable a person to stop abusing cocaine,” Dr. Luedtke said.  “However, an inhibitor of the D3 dopamine receptor might represent a therapeutic tool for people who are committed to a rehabilitation process by blocking the rewarding effects of cocaine.”

Dr. Luedtke’s research is funded by a grant from the National Institute on Drug Abuse and will be performed in collaboration with associates at the University of Pennsylvania School of Medicine and Arizona State University.

Recent News

Techstars Demo Day.
  • On Campus
|Dec 1, 2022

Techstars Demo Day brings innovation to the historic stockyards

For the last 13 weeks, the founders of 10 of the world’s most innovative startups have been in Fort Worth perfecting their new physical health technology. They are part of the world’s first physical health accelerator, and now they are ready to show the fruits of their labor. Techstars Demo D...
Dr. Sid O'bryant Award
  • Our People
|Dec 1, 2022

HSC named the winner of the D Magazines 2022 Achievement in Medical Research Award

The extensive research done by Dr. Sid O’Bryant and his team at the Institute of Translational Research has earned the University of North Texas Health Science Center at Fort Worth the 2022 Medical Research Award by D Magazine. Dr. O’Bryant, the executive director of the ITR and a professor at t...
Dr. John Licciardone
  • Our People
|Nov 30, 2022

Key study results from HSC’s PRECISION Pain Research Registry published in JAMA Network Open

The Journal of the American Medical Association – Network Open has published findings from a recent HSC study about chronic lower back pain, race and the patient-physician relationship. The study revealed that Black patients reported worse outcomes for low back pain intensity and back-related d...
Ram flyer
  • Community
|Nov 23, 2022

Free pop-up medical, vision and dental clinic is just a week away

  The University of North Texas Health Science Center at Fort Worth and Remote Area Medical – RAM® — a nonprofit provider of pop-up clinics that delivers free quality dental, vision and medical care to those in need — are bringing the free health care clinic to Dallas on Dec. 3 and 4....